Expression of matrix metalloproteinase-2 and -9 and of tissue inhibitor of matrix metalloproteinase-1 in liver regeneration from oval cells in rat.
Oval cells participate in liver regeneration when hepatocyte replication is impaired. These precursor cells proliferate in periportal regions and organize in ductules. They are surrounded by a basement membrane, the degradation of which by matrix metalloproteinases (MMP) might trigger their terminal differentiation into hepatocytes. We studied the expression of MMP-2 and MMP-9 and that of one of their tissue inhibitors (TIMP-1) in a model of hepatic regeneration from precursor cells. Regeneration was induced by treating rats with 2-acetylaminofluorene followed by partial hepatectomy. MMP-2 and MMP-9 hepatic expression paralleled oval cell number with a peak at day 9-14 after hepatectomy. They were mainly detected in oval cells. TIMP-1 mRNA and oncostatin M receptor mRNA, a major regulator of TIMP-1 synthesis, markedly increased from day 1 after surgery until day 9 and then declined; they were mainly detected in interlobular bile duct cells and oval cells until day 14. In agreement with the in vivo data, the WB-F344 liver precursor cell line expressed MMP-2 and MMP-9, as well as TIMP-1 and oncostatin M receptor. These data suggest that (a) early increased TIMP-1 synthesis by biliary and oval cells favors basement membrane deposition around proliferating ductular structures through MMP inhibition, (b) delayed increased MMP expression, concomitant to decreased TIMP-1 synthesis, leads to basement membrane degradation, preceding oval cell differentiation, (c) the oncostatin M pathway might play a major role in increased TIMP-1 synthesis.
Pham Van
T
T
INSERM U841, Université Paris 12, AP-HP, Groupe Hospitalier Henri Mondor-Albert Chenevier, Département de Pathologie, Créteil, F-94000 France.
Couchie
D
D
Martin-Garcia
N
N
Laperche
Y
Y
Zafrani
E S
ES
Mavier
P
P
D000818:Animals; D002478:Cells, Cultured; D015971:Gene Expression Regulation, Enzymologic; D022781:Hepatocytes / Q000201:enzymology; D017403:In Situ Hybridization; D008099:Liver / Q000166:cytology* / Q000201:enzymology*; D008115:Liver Regeneration / Q000235:genetics; D008297:Male; D020778:Matrix Metalloproteinase 2 / Q000235:genetics / Q000378:metabolism*; D020780:Matrix Metalloproteinase 9 / Q000235:genetics / Q000378:metabolism*; D053683:Oncostatin M / Q000235:genetics / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344; D053677:Receptors, Oncostatin M / Q000235:genetics / Q000378:metabolism; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000235:genetics / Q000378:metabolism*
D053677:Receptors, Oncostatin M; D019715:Tissue Inhibitor of Metalloproteinase-1; D053683:Oncostatin M; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9